A clinically positioned GLP-1 metabolic support product provides a credible foundation for building a broader brand ecosystem that may include gut health, muscle preservation, collagen support, energy optimization, and longevity nutrition
It is generated by UV exposure, pollution, chronic stress, processed foods, alcohol and intense training all features of a typical Dubai lifestyle
Originally approved by the FDA for the treatment of adult obesity in 2014, the drug received authorisation in 2020 for obesity in adolescents aged 12-17 years old (Mller, Blher, Tschp, DiMarchi)
The injectable Wegovy, in contrast, can be taken at any time of day with or without food, offering much more flexibility
Semaglutides maximum approved dose for weight management is 2.4mg weekly